Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Dihydroberberine (DHB)

Dihydroberberine (GlucoVantage) · also known as Dihydroberberine, DHB, GlucoVantage, Reduced berberine

Dihydroberberine is the reduced form of berberine. After oral intake it can be converted to berberine in the body and raise plasma berberine exposure. Human pharmacokinetic studies have very small samples, and AMPK activation in humans has not been directly shown.

Typical dose: 100–200 mg, 1–2 times daily, taken 15 minutes before a high-carbohydrate meal
Absorption and forms: Dihydroberberine can be converted to berberine in the body and can raise plasma berberine exposure. However, existing human pharmacokinetic studies have very small samples. Its doses and formulations cannot be treated as directly equivalent to berberine hydrochloride, and there are no reliable comparisons of how often gastrointestinal side effects occur.

Clinical uses and human evidence

Blood sugar and insulin resistance

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Moon 2021 · Nutrients · Randomized crossover trial · n=5 — Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial

Mechanisms of action

mTORC1 allosteric inhibition and macroautophagy induction

★★★☆☆Mechanism evidence: grade CSecondary target

In some mouse models, dihydroberberine can affect mTOR-related signaling, for example the Rheb/mTOR pathway in an ovarian insufficiency model. These results do not directly show that mTORC1 is blocked in humans at usual oral doses, and they do not show that autophagy flux increases.

References (1)
  1. Deng et al. 2024 · Mouse study: dihydroberberine affects Rheb/mTOR signaling in an ovarian insufficiency model

Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair

★★☆☆☆Mechanism evidence: grade CSecondary target

In mouse colitis models, dihydroberberine can raise tight junction proteins and mucin-related markers. Local exposure in the gut makes this result biologically plausible. However, there is no direct human evidence for the same mechanism, and neither ileal ZO-1 upregulation nor a microbiota-mediated pathway has been confirmed.

References (1)
  1. Li et al. 2021 · Mouse colitis study: dihydroberberine raised tight junction proteins and mucin-related markers

AMPK sensing of cellular energy deficit and metabolic reprogramming

★★☆☆☆Mechanism evidence: grade DSecondary target

In isolated mitochondria experiments, dihydroberberine can affect respiration, and animal studies of berberine also show pathway changes. However, these results do not directly show that oral dihydroberberine activates AMPK in humans, and it is unclear whether the required concentrations can be reached.

References (2)
  1. Turner et al. 2008 · Cell, isolated mitochondria and rodent study: dihydroberberine affected respiration in isolated mitochondria; animal metabolic outcomes alone cannot prove AMPK activation in vivo
  2. 2022 · Human pharmacokinetic crossover study: only 5 participants per treatment; dihydroberberine raised plasma berberine exposure; human AMPK was not measured

Safety and drug interactions

Use with caution during hypoglycemic episodes. When combined with insulin or other glucose-lowering drugs, monitor blood glucose and watch for hypoglycemia. Contraindicated in pregnant and breastfeeding women. Safety data for long-term use are limited. The compound may affect liver enzymes such as CYP3A4 and drug transporters, so use caution when combining it with other drugs.

Low blood sugar risk

Works the same way as berberine. Each of these may lower blood sugar. Taken together, especially on an empty stomach or alongside antidiabetic drugs, they may cause low blood sugar symptoms such as palpitations, shaking and cold sweats.

Inhibition of drug metabolism (CYP3A4 and others)

Same as berberine. Each of these can inhibit the liver enzymes that metabolize drugs (mainly CYP3A4) or drug transporter proteins, raising blood levels of some prescription drugs.

With Digoxin Needs attention

Digoxin

Dihydroberberine is a derivative of berberine and may have similar effects, but there are no direct human studies. If the two are taken together, digoxin levels should be monitored.

Open in the interactive app ›